Phase 4 Study of Single Dose of Oral Montelukast When Adding to Standard Treatment in Acute Moderate to Severe Wheezing in Preschool Children.

NCT01304901 Phase 4 COMPLETED

The purpose of this study is to determine if adding single dose of oral montelukast to the standard treatment of systemic glucocorticoids plus short acting beta-2 agonist for treatment of acute wheezing provide additional clinical benefit in the emergency room.

Details

Lead sponsor	Kecioren Education and Training Hospital
Phase	Phase 4
Status	COMPLETED
Enrolment	80
Start date	2010-04
Completion	2010-12

Conditions

• Asthma
• Acute Asthma

Interventions

• montelukast 4 mg granule
• Montelukast placebo granüle

Primary outcomes

• Difference of pulmonary index score from baseline to 120 minutes. — 0 to 120 minutes
  İmprovment of pulmonary index score from 0 to 120 minutes was compared bwtween the montelukast and placebo groups.

Countries

Turkey (Türkiye)